Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Shareholders Give Permission for Reverse Stock Split

NEW YORK, March 1 (GenomeWeb News) - Orchid BioSciences' shareholders have approved a potential reverse stock split, Orchid said Friday.


Shareholders gave the board of directors permission on Friday to implement a reverse stock split, at a ratio between one-for-three shares to one-for-seven-shares, anytime before Orchid's annual meeting, scheduled for June 11. The reverse split would affect all outstanding shares of Orchid's common stock.


Orchid hopes that a reverse stock split would allow it to market its stock to new investors, and to make its stock price less volatile, the company said.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.